Skip to main content
SpringerLink
Log in

The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

A major prognostic marker for neuroblastoma (Nb) is N-myc gene amplification, which predicts a poor clinical outcome. We sought genes differentially expressed on a consistent basis between multiple human Nb cell lines bearing normal versus amplified N-myc, in hopes of finding target genes that might clarify how N-myc overexpression translates into poor clinical prognosis. Using differential display, we find the previously described growth-inhibitory gene Ndrg1 is strongly repressed in all tested Nb cell lines bearing N-myc amplification, as well as in a neuroepithelioma line with amplified c-myc. Overexpression of N-myc in non-amplified Nb cells leads to repression of Ndrg1, as does activation of an inducible c-myc transgene in fibroblasts. Conversely, N-myc downregulation in N-myc-amplified Nb cells results in re-expression of the Ndrg1, and stimuli known to induce Ndrg1 do so in Nb cells while simultaneously down-regulating N-myc. Relevant to these results, we demonstrate an in vitro interaction of Myc protein with the Ndrg1 core promoter. We also find that Ndrg1 levels increase dramatically during in vitro differentiation of two cell lines modeling neural and glial development, while c- and N-myc levels decline. Our results combined with previous information on the Ndrg1 gene product suggest that downregulation of this gene is an important component of N-Myc effects in neuroblastomas with poor clinical outcome. In support of this notion, we find that re-expression of Ndrg1 in high-Myc Nb cells results in smaller cells with reduced colony size in soft-agar assays, further underscoring the functional significance of this gene in human neuroblastoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berthold F: Overview: Biology of neuroblastoma. In: C. Pochedly (ed). Neuroblastoma: Tumor Biology and Therapy. CRC Press, 1990, pp 1-27

  2. Brodeur GM, Castleberry RP: Neuroblastoma. In: PA Pizzo, DG Poplack (eds). Principles and Practice of Pediatric Oncology. Lippincott, PA, 1993, pp 739-767

    Google Scholar 

  3. Reynolds CP, Tomayko MM, Donner L, Helson L, Seeger RC, Triche TJ, Brodeur GM: Biological classification of cell lines derived from human extra-cranial neural tumors. Adv Neuroblastoma Res 2: 291-306, 1988

    Google Scholar 

  4. DePinho RA, Schreiber-Agus N, Alt, FW: myc Family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57: 1-46, 1991

    Google Scholar 

  5. Henriksson M, Lüscher B: Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv Cancer Res 68: 109-182, 1996

    Google Scholar 

  6. Seeger RC, Brodeur GM, Sather H et al.: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116, 1985

    Google Scholar 

  7. Peters MA, Taparowsky EJ: Target genes and cellular regulators of the Myc transcription complex. Crit Revs Euk Gene Expr 8: 277-296, 1998

    Google Scholar 

  8. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR: Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 97: 3260-3265, 2000

    Google Scholar 

  9. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM: Targeted expression of MYCN causes neuroblastoma in transgenic mice. Embo J 16: 2985-2995, 1997

    Google Scholar 

  10. Li LH, Nerlov C, Prendergast G, MacGregor D, Ziff EB: c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. Embo J 13: 4070-4079, 1994

    Google Scholar 

  11. Judware R, Culp LA: Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: Differential regulation of α2, β3 and α1. Oncogene 14: 1341-1350, 1997

    Google Scholar 

  12. Breit S, Ashman K, Wilting J, Rossler J, Hatzi E, Fotsis T, Schweigerer L: The N-myc oncogene in human neuroblastoma cells: Down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res 60: 4596-4601, 2000

    Google Scholar 

  13. Claassen GF, Hann SR: Myc-mediated transformation: The repression connection. Oncogene 18: 2925-2933, 1999

    Google Scholar 

  14. Chambery D, Mohseni-Zadeh S, de Galle B, Babajko S: N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Cancer Res 59: 2898-2902, 1999

    Google Scholar 

  15. Boon K, Caron HN, van Asperen R, Valentijn L, Hermus M-C, van Sluis P, Roobeek I, Weis I, Voute PA, Schwab M, Versteeg R: N-myc enhances the expression of a a large set of genes functioning in ribosome biogenesis and protein synthesis. Embo J 20, 1383-1393, 2001

    Google Scholar 

  16. Liang P, Averboukh L, Pardee AB: Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimization. Nucleic Acids Res 21: 3269-3275, 1993

    Google Scholar 

  17. Kokame K, Kato H, Miyata T: Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. J Biol Chem 271: 29659-29665, 1996

    Google Scholar 

  18. van Belzen N, Dinjens WNM, Diesveld MPG et al.: A novel gene up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasm. Lab Invest 77: 85-92, 1997

    Google Scholar 

  19. Lin T-M, Chang C: Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone. Proc Natl Acad Sci USA 94: 4988-4993, 1997

    Google Scholar 

  20. Zhou D, Salnikow K, Costa, M: Cap43, a novel gene specifically induced by Ni2+ compound. Cancer Res 58: 2182-2189, 1998

    Google Scholar 

  21. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW: Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58: 4439-4444, 1998

    Google Scholar 

  22. Shimono A, Okuda T, Kondoh H: N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Devel 83: 39-52, 1999

    Google Scholar 

  23. Schwab M, Alitoal K, Klempnauer K-H, Varmus, HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305: 245-248, 1983

    Google Scholar 

  24. Eggert A, Ho R, Ikegaki N, Liu X, Brodeur GM: Different effects of TrkA expression in neuroblastoma cell lines with and without MYCN amplification. Med Ped Oncol 35: 623-627, 2000

    Google Scholar 

  25. Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM: Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene 5: 1821-1827, 1990

    Google Scholar 

  26. Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds P, Israel MA: Differential proto-oncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Inv 80: 804-811, 1987

    Google Scholar 

  27. Bansal R, Pfeiffer SE: Regulated galactolipid synthesis and cell surface expression in Schwann cell line D6P2T. J Neurochem 49:1902-1911, 1987

    Google Scholar 

  28. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI: A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23: 1686-1690, 1995

    Google Scholar 

  29. Greenberg ME, Bender TP: Analysis of RNA structure and synthesis. In: Ausubel et al. (eds). Current Protocols in Molecular Biology. Wiley & Sons, 1992

  30. Galderisi U, DiBernardo G, Cipollaro M et al.: Differentiation and apoptosis of neuroblastoma cells: Role of N-myc gene product. J Cell Biochem 73: 97-105, 1999

    Google Scholar 

  31. Ikegaki N, Bukovsky J, Kennett RH: Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. Proc Natl Acad Sci USA 83: 5929-5933, 1986

    Google Scholar 

  32. Foley KP, Eisenman RN: Two MAD tails: What the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochim Biophys Acta 1423: M37-M47, 1999

    Google Scholar 

  33. Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S: High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' Tumor. Cancer Res 59: 4301-4307, 1999

    Google Scholar 

  34. Panero NJ, Yuen PK, Sakazume T, Fortina P, Kricka LJ, Wilding P: Evaluation of DNA fragment sizing and quantification by the Agilent 2100 Bioanalyzer. Clin Chem 46: 1851-1853, 2000

    Google Scholar 

  35. Nachamkin I, Panaro NJ, Li M, Ung H, Yuen PK, Kricka LJ, Wilding P: Agilent 2100 Bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene. J Clin Microbiol 39: 754-757

  36. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H: Sequence specific DNA binding by the c-Myc protein. Science 250: 1149-1151, 1990

    Google Scholar 

  37. Ciccarona V, Spengler BA, Meyers MB, Biedler JL, Ross RA: Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res 49: 219-225, 1989

    Google Scholar 

  38. Rabbitts PH, Watson JV, Lamond A et al.: Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. Embo J 4: 2009-2015, 1985

    Google Scholar 

  39. Thiele CJ, Reynolds P Israel MA: Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313: 404-406, 1985

    Google Scholar 

  40. Peverali FA, Orioli D, Tonon L et al.: Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpression. Oncogene 12: 457-462, 1996

    Google Scholar 

  41. Agrawal S, Jiang ZW, Zhao QY et al.: Mixed-backbone oligonucleotides as second-generation antisense oligonucleotides: In vitro and in vivo studies. Proc Natl Acad Sci USA 94: 2620-2625, 1997

    Google Scholar 

  42. Schmajuk G, Sierakowska H, Kole R: Antisense oligonucleotides with different backbones. J Biol Chem 274: 21713-21789, 1999

    Google Scholar 

  43. Gandelman KY, Pfeiffer SE, Carson JH: Cyclic AMP regulation of P0 glycoprotein and myelin basic protein gene expression in semi-differentiated peripheral neurinoma cell line D6P2T. Development 106: 389-398, 1989

    Google Scholar 

  44. Lemaitre JM, Buckle RS, Mechali M: c-Myc in the control of cell proliferation and embryonic development. Adv Cancer Res 70: 95-144, 1996

    Google Scholar 

  45. Marcu KB, Bossone SA, Patel AJ: Myc function and regulation. Ann Rev Biochem 61: 809-860, 1992

    Google Scholar 

  46. Luo Q, Harmon E, Timms BG, Kretzner L: Novel expression patterns of the Myc/Max/Mad transcription factor network in developing murine prostate gland. J Urol 166: 1071-1077, 2001

    Google Scholar 

  47. Szeberenyi J: Gene activation pathways of nerve growth factor signaling: A minireview. Neurobiology 4: 1-11, 1996

    Google Scholar 

  48. Lee LA, Dang CV: c-Myc transrepression and cell transformation. Curr Topics Microbiol Immunol 224: 131-135, 1997

    Google Scholar 

  49. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB: Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60: 749-755, 2000

    Google Scholar 

  50. Xu B, Lin L, Rote NS: Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. Biol Reprod 61: 681-686, 1999

    Google Scholar 

  51. Kyle V, Bernstein M, Leclerc, J Met et al.: Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53: 5269-5273, 1993

    Google Scholar 

  52. Davidoff AM, Pence JC, Shorter NA, Iglehart JD, Marks JR: Expression of p53 in human neuroblastoma-and neuroepithelioma-derived cell lines. Oncogene 7: 127-133, 1992

    Google Scholar 

  53. Brewer JW, Hendershot LM, Sherr CJ, Diehl JA: Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proc Natl Acad Sci USA 96: 8505-8510, 1999

    Google Scholar 

  54. Smale ST, Jain A, Kaufmann J, Emami KH, Lo K, Garraway IP: The initiator element: A paradigm for core promoter heterogeneity within metazoan protein-coding genes. Cold Spring Harbor Symp Quant Biol 63: 21-31, 1998

    Google Scholar 

  55. Nesbit CE, Tersak JM, Prochownik EV: MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cellular and Molecular Biology, Division of Basic Biomedical Sciences, University of South Dakota School of Medicine, Vermillion, SD, USA

    Jun Li & Leo Kretzner

  2. Stine-Haskell Research Center, Incyte Genomics Inc., 1090 Elkton Road, S112, Newark, DE, 19711, USA

    Jun Li

  3. Cell and Tumor Biology Department, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA, 91010, USA

    Leo Kretzner

Authors
  1. Jun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leo Kretzner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Kretzner, L. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc . Mol Cell Biochem 250, 91–105 (2003). https://doi.org/10.1023/A:1024918328162

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024918328162

Search

Navigation